\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ appeared\\ thin\\.\\ \\ laboratory\\ values\\ were\\ remarkable\\ for\\ a\\ hgb\\ of\\ 10\\.8\\,\\ hct\\ of\\ 32\\.4\\,\\ cea\\ of\\ 10\\.6\\ \\(nl\\ 0\\.0\\-4\\.6\\)\\,\\ ca\\ 27\\-29\\ of\\ 67\\ \\(nl\\ 0\\-37\\)\\,\\ and\\ ammonia\\ of\\ 89\\ \\(nl\\ 7\\-33\\)\\.\ \(0\)\
\-\ this\\ woman\\ had\\ known\\ metastatic\\ breast\\ cancer\\,\\ and\\ these\\ studies\\ were\\ obtained\\ for\\ routine\\ follow\\-up\\.\\ she\\ is\\ being\\ treated\\ with\\ chemotherapy\\ and\\ is\\ followed\\ with\\ serial\\ bone\\ scans\\ to\\ monitor\\ response\\.\ \(0\)\
\-\ anterior\\ and\\ posterior\\ delayed\\ whole\\ body\\ images\\ demonstrate\\ abnormal\\ increased\\ radiotracer\\ uptake\\ in\\ the\\ lower\\ lumbar\\ spine\\,\\ as\\ well\\ as\\ a\\ focal\\ area\\ of\\ increased\\ uptake\\ in\\ the\\ soft\\ tissues\\ superior\\ to\\ the\\ right\\ kidney\\.\\ \\ additionally\\,\\ increased\\ radiotracer\\ uptake\\ is\\ seen\\ bilaterally\\ about\\ the\\ shoulders\\,\\ knees\\ \\(rt\\>lt\\)\\,\\ and\\ ankles\\ \\(lt\\>rt\\)\\.\\ \\ \\ contrast\\ abdominal\\ ct\\ image\\ demonstrates\\ multiple\\ masses\\ throughout\\ the\\ liver\\,\\ largely\\ replacing\\ normal\\ hepatic\\ parenchyma\\.\\ \\ coronal\\ reformat\\ nicely\\ demonstrates\\ the\\ densely\\ sclerotic\\ lesion\\ within\\ the\\ l4\\ vertebral\\ body\\ corresponding\\ to\\ the\\ abnormal\\ focus\\ of\\ radiotracer\\ accumulation\\ on\\ the\\ bone\\ scan\\.\ \(0\)\
\-\ metastatic\\ breast\\ cancer\\ to\\ the\\ liver\\ and\\ lumbar\\ spine\\.\\ \\ other\\ areas\\ of\\ increased\\ radiotracer\\ uptake\\ represent\\ arthritis\\ and\\/or\\ stress\\ changes\\.\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ trauma\ \(1087\)\
\-\ arthritis\ \(395\)\
\-\ benign\\ bone\\ dysplasias\ \(1\)\
\-\ paget\\'s\\ disease\ \(1\)\
\-\ osteomyelitis\ \(170\)\
\-\ 50\\-year\\ old\\ woman\\ presents\\ for\\ skeletal\\ scintigraphy\\ to\\ monitor\\ treatment\\ response\\.\ \(1\)\
\-\ one\\ of\\ the\\ most\\ common\\ applications\\ of\\ skeletal\\ scinitgraphy\\ is\\ in\\ evaluating\\ patients\\ with\\ extraskeletal\\ malignancy\\ for\\ the\\ presence\\ of\\ metastatic\\ disease\\.\\ \\ skeletal\\ scintigraphy\\ has\\ the\\ advantage\\ of\\ being\\ able\\ to\\ survey\\ the\\ entire\\ skeleton\\.\\ \\ while\\ it\\ is\\ a\\ sensitive\\ test\\,\\ it\\ is\\ not\\ specific\\.\\ \\ abnormal\\ uptake\\ on\\ a\\ bone\\ scan\\ may\\ represent\\ metastatic\\ disease\\,\\ arthritis\\,\\ areas\\ of\\ trauma\\ or\\ infection\\,\\ as\\ well\\ as\\ benign\\ bone\\ dysplasias\\.\\ \\ thus\\,\\ the\\ differential\\ can\\ be\\ quite\\ broad\\,\\ and\\ it\\ is\\ useful\\ to\\ further\\ evaluate\\ questionable\\ areas\\ with\\ further\\ imaging\\,\\ as\\ was\\ done\\ in\\ this\\ case\\.\ \(0\)\
\-\ skeletal\\ scintigraphy\\ is\\ commonly\\ used\\ for\\ inital\\ staging\\ in\\ patients\\ with\\ malignancy\\,\\ as\\ well\\ as\\ in\\ monitoring\\ response\\ to\\ therapy\\,\\ and\\ in\\ detecting\\ areas\\ at\\ risk\\ for\\ pathologic\\ fracture\\.\\ \\ the\\ bone\\ scan\\ in\\ this\\ patient\\ demonstrates\\ several\\ areas\\ of\\ abnormal\\ uptake\\ in\\ the\\ skeleton\\,\\ as\\ well\\ as\\ a\\ focal\\ region\\ of\\ soft\\ tissue\\ uptake\\.\\ \\ this\\ is\\ an\\ important\\ reminder\\ that\\ when\\ evaluating\\ a\\ bone\\ scan\\ one\\ must\\ look\\ for\\ not\\ only\\ abnormal\\ bone\\ uptake\\,\\ but\\ also\\ soft\\ tissue\\ uptake\\,\\ as\\ soft\\ tissue\\ metastases\\ may\\ accumulate\\ sufficient\\ radiotracer\\ to\\ be\\ visualized\\.\\ \\ \ \(0\)\
\-\ breast\\ cancer\\,\\ along\\ with\\ prostate\\,\\ lung\\,\\ thyroid\\,\\ and\\ renal\\ cancer\\,\\ is\\ one\\ of\\ the\\ most\\ common\\ nonosseous\\ tumors\\ to\\ metastasize\\ to\\ bone\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ uptake\\:\\ 0\\.0664235887440172\ \(0\)\
\-\ radiotracer\\:\\ 0\\.043339181376784754\ \(0\)\
\-\ bone\\:\\ 0\\.04154546115899746\ \(0\)\
\-\ skeletal\\:\\ 0\\.036699118033320946\ \(0\)\
\-\ nl\\:\\ 0\\.03488988600760937\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.032382853188628956\ \(0\)\
\-\ areas\\:\\ 0\\.031253773600500724\ \(0\)\
\-\ as\\:\\ 0\\.02809951099769843\ \(0\)\
\-\ response\\:\\ 0\\.02793207998356462\ \(0\)\
\-\ dysplasias\\:\\ 0\\.027902709352904904\ \(0\)\
\-\ abnormal\\:\\ 0\\.02649013304690121\ \(0\)\
\-\ lt\\:\\ 0\\.02530341804527177\ \(0\)\
\-\ cancer\\:\\ 0\\.024427524037954482\ \(0\)\
\-\ rt\\:\\ 0\\.02416270385193485\ \(0\)\
\-\ arthritis\\:\\ 0\\.023809124674193376\ \(0\)\
\-\ metastatic\\:\\ 0\\.023381623952348808\ \(0\)\
\-\ skeleton\\:\\ 0\\.022747823850045167\ \(0\)\
\-\ monitor\\:\\ 0\\.021149020458195958\ \(0\)\
\-\ scan\\:\\ 0\\.02080236052550416\ \(0\)\
\-\ evaluating\\:\\ 0\\.02067424092791339\ \(0\)\
\-\ breast\\:\\ 0\\.02056016050324273\ \(0\)\
\-\ 7\\-33\\:\\ 0\\.01916417048688369\ \(0\)\
\-\ 50\\-year\\:\\ 0\\.01916417048688369\ \(0\)\
\-\ scinitgraphy\\:\\ 0\\.01916417048688369\ \(0\)\
\-\ increased\\:\\ 0\\.01817812853738831\ \(0\)\
\-\ soft\\:\\ 0\\.018095015339074347\ \(0\)\
\-\ 32\\.4\\:\\ 0\\.017657328790014245\ \(0\)\
\-\ 0\\.0\\-4\\.6\\:\\ 0\\.017657328790014245\ \(0\)\
\-\ ammonia\\:\\ 0\\.017657328790014245\ \(0\)\
\-\ reminder\\:\\ 0\\.017657328790014245\ \(0\)\
\-\ nonosseous\\:\\ 0\\.017657328790014245\ \(0\)\
\-\ well\\:\\ 0\\.016809399591031747\ \(0\)\
\-\ applications\\:\\ 0\\.016775882902822583\ \(0\)\
\-\ represent\\:\\ 0\\.016317058221476225\ \(0\)\
\-\ 27\\-29\\:\\ 0\\.0161504870931448\ \(0\)\
\-\ 0\\-37\\:\\ 0\\.0161504870931448\ \(0\)\
\-\ extraskeletal\\:\\ 0\\.0161504870931448\ \(0\)\
\-\ \\,\\:\\ 0\\.01588950384557991\ \(0\)\
\-\ lumbar\\:\\ 0\\.015798847276845274\ \(0\)\
\-\ reformat\\:\\ 0\\.01566539241637478\ \(0\)\
\-\ one\\:\\ 0\\.015102595978112896\ \(0\)\
\-\ accumulate\\:\\ 0\\.01493393103241562\ \(0\)\
\-\ 10\\.8\\:\\ 0\\.014387595318761475\ \(0\)\
\-\ inital\\:\\ 0\\.014387595318761475\ \(0\)\
\-\ malignancy\\:\\ 0\\.014356911642615287\ \(0\)\
\-\ 10\\.6\\:\\ 0\\.013588193622836873\ \(0\)\
\-\ advantage\\:\\ 0\\.013588193622836873\ \(0\)\
\-\ cea\\:\\ 0\\.013427089335546172\ \(0\)\
\-\ densely\\:\\ 0\\.013427089335546172\ \(0\)\
\-\ tissue\\:\\ 0\\.013209268620343\ \(0\)\
\-\ replacing\\:\\ 0\\.013136803699405905\ \(0\)\
\-\ metastasize\\:\\ 0\\.013136803699405905\ \(0\)\
\-\ 89\\:\\ 0\\.013005011043283223\ \(0\)\
\-\ being\\:\\ 0\\.01294690424695895\ \(0\)\
\-\ benign\\:\\ 0\\.012821958117535658\ \(0\)\
\-\ liver\\:\\ 0\\.012809658742750973\ \(0\)\
\-\ ankles\\:\\ 0\\.012651709022635885\ \(0\)\
\-\ nicely\\:\\ 0\\.01254564344835451\ \(0\)\
\-\ it\\:\\ 0\\.012527272073041412\ \(0\)\
\-\ \\>\\:\\ 0\\.012344206585515497\ \(0\)\
\-\ detecting\\:\\ 0\\.012255357812214243\ \(0\)\
\-\ spine\\:\\ 0\\.012235232808718903\ \(0\)\
\-\ is\\:\\ 0\\.012223712573580991\ \(0\)\
\-\ demonstrates\\:\\ 0\\.012173616532520777\ \(0\)\
\-\ disease\\:\\ 0\\.012145543836658296\ \(0\)\
\-\ largely\\:\\ 0\\.012081351925967425\ \(0\)\
\-\ body\\:\\ 0\\.01206636396821341\ \(0\)\
\-\ further\\:\\ 0\\.01181497452956634\ \(0\)\
\-\ sufficient\\:\\ 0\\.011563067092391343\ \(0\)\
\-\ survey\\:\\ 0\\.011435152961906706\ \(0\)\
\-\ shoulders\\:\\ 0\\.011256374487478507\ \(0\)\
\-\ quite\\:\\ 0\\.011199906038775765\ \(0\)\
\-\ 67\\:\\ 0\\.01114486732576644\ \(0\)\
\-\ for\\:\\ 0\\.011095124001084795\ \(0\)\
\-\ l4\\:\\ 0\\.010987648496245513\ \(0\)\
\-\ whole\\:\\ 0\\.010937671282713559\ \(0\)\
\-\ knees\\:\\ 0\\.010794284396209651\ \(0\)\
\-\ staging\\:\\ 0\\.010703691577947547\ \(0\)\
\-\ focal\\:\\ 0\\.010610841757123486\ \(0\)\
\-\ questionable\\:\\ 0\\.010492466037830921\ \(0\)\
\-\ hgb\\:\\ 0\\.010337120463956694\ \(0\)\
\-\ look\\:\\ 0\\.010337120463956694\ \(0\)\
\-\ paget\\:\\ 0\\.01029995865230604\ \(0\)\
\-\ monitoring\\:\\ 0\\.010263421438574779\ \(0\)\
\-\ to\\:\\ 0\\.010212498245375758\ \(0\)\
\-\ trauma\\:\\ 0\\.010160907746773605\ \(0\)\
\-\ appeared\\:\\ 0\\.010123120305667014\ \(0\)\
\-\ remarkable\\:\\ 0\\.010089415552327959\ \(0\)\
\-\ hct\\:\\ 0\\.010089415552327959\ \(0\)\
\-\ sensitive\\:\\ 0\\.010089415552327959\ \(0\)\
\-\ accumulation\\:\\ 0\\.009897475102011267\ \(0\)\
\-\ prostate\\:\\ 0\\.009867070228153137\ \(0\)\
\-\ common\\:\\ 0\\.009722900921549553\ \(0\)\
\-\ useful\\:\\ 0\\.009693064341906319\ \(0\)\
\-\ broad\\:\\ 0\\.009638025628896991\ \(0\)\
\-\ patients\\:\\ 0\\.009615541736374026\ \(0\)\
\-\ corresponding\\:\\ 0\\.009455674576765032\ \(0\)\
\-\ values\\:\\ 0\\.009287442699340205\ \(0\)\
\-\ serial\\:\\ 0\\.009264438113839039\ \(0\)\
\-\ thus\\:\\ 0\\.009241674418475353\ \(0\)\
\-\ entire\\:\\ 0\\.009131299798098345\ \(0\)\
\-\ able\\:\\ 0\\.008756579741705331\ \(0\)\
\-\ ca\\:\\ 0\\.008650514167423958\ \(0\)\
\-\ scans\\:\\ 0\\.008650514167423958\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.008633328994582407\ \(0\)\
\-\ woman\\:\\ 0\\.008582186728212636\ \(0\)\
\-\ most\\:\\ 0\\.008577544094469897\ \(0\)\
\-\ must\\:\\ 0\\.008468559778561681\ \(0\)\
\-\ were\\:\\ 0\\.008436027550825745\ \(0\)\
\-\ this\\:\\ 0\\.008357714898383765\ \(0\)\
\-\ focus\\:\\ 0\\.008345184090317226\ \(0\)\
\-\ important\\:\\ 0\\.008345184090317226\ \(0\)\
\-\ sclerotic\\:\\ 0\\.00831540399388644\ \(0\)\
\-\ in\\:\\ 0\\.008244728415787597\ \(0\)\
\-\ may\\:\\ 0\\.00814925377781793\ \(0\)\
\-\ stress\\:\\ 0\\.008144813525535363\ \(0\)\
\-\ pathologic\\:\\ 0\\.008131183932027546\ \(0\)\
\-\ additionally\\:\\ 0\\.008051153555673816\ \(0\)\
\-\ test\\:\\ 0\\.007936374891397792\ \(0\)\
\-\ metastases\\:\\ 0\\.007936374891397792\ \(0\)\
\-\ parenchyma\\:\\ 0\\.007911671068244933\ \(0\)\
\-\ \\(\\:\\ 0\\.007851757893955005\ \(0\)\
\-\ and\\/or\\:\\ 0\\.007851112471499354\ \(0\)\
\-\ hepatic\\:\\ 0\\.007757596416969592\ \(0\)\
\-\ \\)\\:\\ 0\\.007755844479492446\ \(0\)\
\-\ coronal\\:\\ 0\\.007734832721605907\ \(0\)\
\-\ done\\:\\ 0\\.0077011279682668516\ \(0\)\
\-\ specific\\:\\ 0\\.007678944989627195\ \(0\)\
\-\ thin\\:\\ 0\\.007635246773711788\ \(0\)\
\-\ tissues\\:\\ 0\\.007624458101228898\ \(0\)\
\-\ thyroid\\:\\ 0\\.0076137227063580665\ \(0\)\
\-\ delayed\\:\\ 0\\.007560826835359087\ \(0\)\
\-\ visualized\\:\\ 0\\.007519417715857578\ \(0\)\
\-\ evaluate\\:\\ 0\\.007509187517950158\ \(0\)\
\-\ routine\\:\\ 0\\.007448797161195646\ \(0\)\
\-\ vertebral\\:\\ 0\\.007351731348722301\ \(0\)\
\-\ about\\:\\ 0\\.007160994578487504\ \(0\)\
\-\ used\\:\\ 0\\.00712648729771296\ \(0\)\
\-\ commonly\\:\\ 0\\.007009850964034003\ \(0\)\
\-\ tumors\\:\\ 0\\.0069776442558054375\ \(0\)\
\-\ throughout\\:\\ 0\\.0069537985354346235\ \(0\)\
\-\ studies\\:\\ 0\\.006938045473432956\ \(0\)\
\-\ laboratory\\:\\ 0\\.006845851599682752\ \(0\)\
\-\ presence\\:\\ 0\\.006743012214037237\ \(0\)\
\-\ risk\\:\\ 0\\.006728710102954536\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.00665857779378449\ \(0\)\
\-\ obtained\\:\\ 0\\.006604056740747482\ \(0\)\
\-\ kidney\\:\\ 0\\.006544311858804369\ \(0\)\
\-\ masses\\:\\ 0\\.006279548691295842\ \(0\)\
\-\ followed\\:\\ 0\\.00622799102473646\ \(0\)\
\-\ along\\:\\ 0\\.006139247558388078\ \(0\)\
\-\ bilaterally\\:\\ 0\\.006101533127225877\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.0060435586770472656\ \(0\)\
\-\ several\\:\\ 0\\.005971940947222582\ \(0\)\
\-\ superior\\:\\ 0\\.005932051515335199\ \(0\)\
\-\ differential\\:\\ 0\\.005897738759462891\ \(0\)\
\-\ known\\:\\ 0\\.005878371922747434\ \(0\)\
\-\ area\\:\\ 0\\.005873557052465798\ \(0\)\
\-\ while\\:\\ 0\\.005844889651852855\ \(0\)\
\-\ image\\:\\ 0\\.005802585144125219\ \(0\)\
\-\ be\\:\\ 0\\.005729377058017083\ \(0\)\
\-\ only\\:\\ 0\\.005585677518445512\ \(0\)\
\-\ renal\\:\\ 0\\.005581468585778411\ \(0\)\
\-\ treated\\:\\ 0\\.005560545295834477\ \(0\)\
\-\ the\\:\\ 0\\.005409754618837532\ \(0\)\
\-\ infection\\:\\ 0\\.005400036030593059\ \(0\)\
\-\ lung\\:\\ 0\\.0053807806961711875\ \(0\)\
\-\ not\\:\\ 0\\.005368776833660589\ \(0\)\
\-\ changes\\:\\ 0\\.005324017339641436\ \(0\)\
\-\ when\\:\\ 0\\.00532028529916523\ \(0\)\
\-\ region\\:\\ 0\\.0052469591896506795\ \(0\)\
\-\ she\\:\\ 0\\.0052147524814221136\ \(0\)\
\-\ a\\:\\ 0\\.005173040893286103\ \(0\)\
\-\ therapy\\:\\ 0\\.004966610426610028\ \(0\)\
\-\ fracture\\:\\ 0\\.004897987674506041\ \(0\)\
\-\ these\\:\\ 0\\.004834444982517044\ \(0\)\
\-\ anterior\\:\\ 0\\.004784332225571168\ \(0\)\
\-\ abdominal\\:\\ 0\\.0046433026915698155\ \(0\)\
\-\ imaging\\:\\ 0\\.004352334400990441\ \(0\)\
\-\ posterior\\:\\ 0\\.004281822931961845\ \(0\)\
\-\ other\\:\\ 0\\.004281822931961845\ \(0\)\
\-\ demonstrate\\:\\ 0\\.004274895959419654\ \(0\)\
\-\ can\\:\\ 0\\.00421352685319363\ \(0\)\
\-\ lower\\:\\ 0\\.004177961020356223\ \(0\)\
\-\ contrast\\:\\ 0\\.004158208014799794\ \(0\)\
\-\ \\'s\\:\\ 0\\.004095753518189228\ \(0\)\
\-\ case\\:\\ 0\\.0040641400714505884\ \(0\)\
\-\ of\\:\\ 0\\.004052306114712641\ \(0\)\
\-\ had\\:\\ 0\\.0040083691722624095\ \(0\)\
\-\ but\\:\\ 0\\.003961963697898995\ \(0\)\
\-\ multiple\\:\\ 0\\.003912621746694063\ \(0\)\
\-\ presents\\:\\ 0\\.0037948789032780997\ \(0\)\
\-\ lesion\\:\\ 0\\.0037838157086966407\ \(0\)\
\-\ treatment\\:\\ 0\\.0037600368686975805\ \(0\)\
\-\ patient\\:\\ 0\\.0037243127431147304\ \(0\)\
\-\ seen\\:\\ 0\\.00367092959797324\ \(0\)\
\-\ also\\:\\ 0\\.00366221650797859\ \(0\)\
\-\ images\\:\\ 0\\.003563617156411639\ \(0\)\
\-\ within\\:\\ 0\\.0035437639312740905\ \(0\)\
\-\ and\\:\\ 0\\.0035219153295434047\ \(0\)\
\-\ has\\:\\ 0\\.003488478196726691\ \(0\)\
\-\ that\\:\\ 0\\.0032086537577365724\ \(0\)\
\-\ on\\:\\ 0\\.0031473522276757745\ \(0\)\
\-\ normal\\:\\ 0\\.0029122009882589154\ \(0\)\
\-\ ct\\:\\ 0\\.00259848620302618\ \(0\)\
\-\ an\\:\\ 0\\.0025688366614885433\ \(0\)\
\-\ at\\:\\ 0\\.002516876419199202\ \(0\)\
\-\ or\\:\\ 0\\.0021772233673124078\ \(0\)\
\-\ was\\:\\ 0\\.0021484293961167105\ \(0\)\
\-\ right\\:\\ 0\\.001960068932848732\ \(0\)\
\-\ old\\:\\ 0\\.0019020317323092493\ \(0\)\
\-\ \\.\\:\\ 0\\.0015434580911889684\ \(0\)\
\-\ with\\:\\ 0\\.0015261414272594313\ \(0\)\
